The prevalence of a novel somatic mutation (E17K) in the pleckstrin homology domain of AKT1 was investigated in pancreatic cancer using a quantitative pyrosequencing assay. This mutation was un-detectable in pancreatic cancer tissue samples (n=65) and pancreatic cell line (n=10) DNA suggesting that pancreatic cancer progression is mainly dependent on the K-Ras mutation.
AsanoT.YaoY.ZhuJ.LiD.AbbruzzeseJ. L.ReddyS. A.The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene23, 8571–8580 (2004).
2.
BruggeJ.HungM. C.MillsG. B.A new mutational AKTivation in the PI3K pathway. Cancer Cell12, 104–107 (2007).
3.
CarptenJ. D.FaberA. L.HornC.A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature448, 439–444 (2007).
4.
KocherH. M.MearsL.LeaN. C.RajK.MuftiG. J.JAK V617F missense mutation is absent in pancreatic cancer. Gut56, 1174–1175 (2007).
5.
AlmogueraC.ShibataD.ForresterK.MartinJ.ArnheimN.PeruchoM.Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell53, 549–554 (1988).
